DRUG MANUFACTURING EQUIPMENT CHANGES DO NOT REQUIRE PRIOR FDA APPROVAL
This article was originally published in The Tan Sheet
Executive Summary
DRUG MANUFACTURING EQUIPMENT CHANGES DO NOT REQUIRE PRIOR FDA APPROVAL when changing "to equipment of the same design and operating principles from the same or a different manufacturer" or when changing "to the same equipment with a different capacity," provided that "the capacity should not exceed 10 times the test batch size," the agency explained. In a draft guidance on manufacturing supplements, FDA noted that such changes would "ordinarily" require only description in a company's annual report. The draft guideline, which applies only to non-sterile drug products, was published in the Dec. 12 Federal Register.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning